Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

Adelphi Targis, S.L

Adelphi Targis, S.L is listed as a small consultant research supplier in the Scientist.com network, with 1 site in 1 country.

View Adelphi Targis, S.L on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 1
Countries 1

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Small consultant

Clinical Consulting

  • Biostatistics Consulting Apply statistical theory and mathematical principals to research
  • Medical Communications Materials Mediate general correspondence and answer inquiries from participants in clinical trials.
  • Patient Advocacy Help patients communicate with their healthcare providers so they get the information they need to make decisions about their health care.

Clinical Trials

  • Investigator Meeting Planning & Execution Investigator planning and meetings ensure that there is proper communication and reliability during a clinical trial. Allows for efficient work flow.
  • Patient Concierge Services Find a liaison between patients and healthcare providers, ensuring a smoother and more comfortable experience throughout the patient's journey.
  • Patient Insights Data, information, and feedback collected from patients to understand their experiences, perspectives, and needs related to a particular health condition or treatment
  • Study/Site Feasibility Study Explore and test study practicality.

Data Science/Bioinformatics

  • Graph-Based Patient Journey Analysis Graph-based patient journey analysis is a method of visualizing and analyzing the pathways patients take through healthcare systems using graph structures, enabling insights into patient experiences, care patterns...
  • RWE/HEOR Data Science and Modeling A process that helps make sense of your clinical data

Drug Development

  • Consulting Services Work with consultants who provide expert advice in various areas of research and technology.

HEOR

  • Comparative Effectiveness The generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care.
  • Cost Benefit Analysis Economic evaluation in which costs and benefits (outcomes) are expressed in monetary units, to determine if the benefits of an intervention outweigh the costs.
  • Decision Analytic Modeling Assess effects, costs and economic outcomes of treatment. These include cost-effectiveness models and budget impact models.
  • Health Economics and Outcomes Research (HEOR) Evaluate data collected during drug development to maximize the value of a therapeutic product.
  • Patient Reported Outcomes (PRO) Assessment of health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician.
  • Systematic Literature Review Summarizes the results of research (that meet pre-defined eligibility criteria for inclusion) and provides a high level of evidence on the outcomes assessed.
Show all 104 services 88 more

Market Access

  • Communication & Advertisement Distribution of a range of materials, through various communication channels, to highlight a message containing scientific-related topics
  • Environmental Analysis Research or strategy related to understanding the market (size, competition, reimbursement, challenges, etc.) and is a tool used to understand if a product can be launched in the market.
  • Health Technology Assessment (HTA) Preparation/Strategy Dossier Development Perform evidence preparation and/or create strategies for the systematic evaluation of the properties, effects, and/or impacts of health care technology.
  • Life Science Reports Life Science reports
  • Market Access - HTA Landscape Assessment Conduct a HTA landscape assessment to evaluate the direct and indirect impact of health technology on a specific region.
  • Market Access Materials Find general strategies and methods used to market a pharmaceutical product or device.
Show all 12 in Market Access 6 more
  • Market Research & Business Intelligence Run market feasibility studies, establish customer needs, improve product performance and analyze competition.
  • Payer Toolkit Communicate product value to payers utilizing digital and mobile technology (For example, Payer-Facing iPad Models).
  • Population Health Analytics Aggregation of patient data across multiple health information technology resources, the analysis of that data into a single, actionable patient record, and the actions through which care providers can improve both...
  • Pricing Strategy Develop value story tailored to a payer audience that will determine the appropriate price for treatment.
  • Value Based Agreements or Outcomes-Based Contracts Collaborate with payer or provider to develop a reimbursement plan outside of the traditional fixed cost-per-unit that ties reimbursement or price to actual health outcomes.
  • Value Dossiers Development Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder...

Medical Communications

  • 1:1 KEE Engagement Management Compliant, individualized planning and documentation of scientific exchange meetings between Medical Science Liaisons (MSLs) and Key External Experts (KEEs).
  • Abstracts Request services related to the writing and review of abstracts
  • Adverse Events Reports Collecting, documenting, and forwarding reports of side effects or safety issues experienced by patients to the pharmacovigilance team for regulatory reporting.
  • Advisory Boards Logistical and content support for organizing panels of external experts to gather critical strategic insights and feedback on therapeutic and product development plans.
  • All Medical Meeting Materials and Content End-to-end service providing slide decks, handouts, training guides, and logistics required to run an internal or external medical meeting successfully.
  • Animated Content Development of diverse visual, interactive digital assets like infographics, data visualizations, and short animations to explain complex medical and scientific concepts simply.
Show all 51 in Medical Communications 45 more
  • Congress Listening/Insights Report Systematic collection, analysis, and summary of key discussions, scientific trends, competitor movements, and data presented at major medical congresses.
  • Consensus reports Develop and submit a report that is a comprehensive examination by an expert panel of a scientific or medical issue.
  • Creation of Non promotional Education/Awareness Content Development of scientifically rigorous, balanced materials (like disease state primers or journal clubs) aimed purely at enhancing clinical understanding, not driving product use.
  • Development of non promotional Medical Education Plan Creation of a strategic, compliant framework outlining educational needs, target audiences, content objectives, and tactical deployment of medical materials without promoting a product.
  • Disease or Drug-Related Literature Curation, development, and compliant distribution of written materials (e.g., abstracts, manuscripts, summaries) related to a specific illness or medicinal product.
  • Educational Content Development Comprehensive development of diverse, multi-channel content assets that offer education and information about a specific therapeutic area or medicinal product.
  • eLearning Modules Development Development of interactive, self-paced digital courses that allow learners (internal staff or external HCPs) to master scientific content or therapeutic knowledge remotely.
  • Faculty and/or Steering Committee Management Oversight and compliant coordination of expert groups involved in clinical trials, publication steering, or educational program development.
  • HCP Recruitment Compliant identification and engagement of appropriate healthcare professionals (HCPs) for advisory boards, speaker programs, or clinical trial participation.
  • HEOR/Value Publications Writing and submission of manuscripts and abstracts focusing on Health Economics and Outcomes Research (HEOR) data, which demonstrate the economic and value proposition of a therapy.
  • Independent Medical Education (IME) Independent Medical Education (IME) refers to accredited or non-accredited educational programs for healthcare professionals funded by pharmaceutical or medical device companies
  • KOL Engagement & Management Building and maintaining compliant, value-driven relationships with Key Opinion Leaders (KOLs) to collaborate on scientific exchange and clinical education initiatives.
  • Literature Monitoring Ongoing, systematic surveillance and analysis of published scientific literature to track emerging data, competitor activities, and changes in clinical understanding.
  • Manuscript Co-Authorship and Publications Planning Manuscript co-authorship and publications planning involve collaborating among researchers to write, organize, and strategize the submission and publication of scientific findings in academic journals, ensuring proper...
  • Medical Academy Training Developing structured, curriculum-based training programs for internal medical affairs teams, focusing on scientific, therapeutic, and compliance knowledge mastery.
  • Medical Affairs Services for non-promotional scientific exchange, supporting the dissemination of accurate medical data and the development of educational content.
  • Medical Affairs Dossiers Develop medical affairs dossiers such as Global Value Dossiers or AMCP Dossiers.
  • Medical Communications Request services related to the creation and development and medical communications content
  • Medical Communications Master Class Design and execution of in-depth, high-level educational sessions led by top Key Opinion Leaders (KOLs) focusing on advanced clinical or scientific topics.
  • Medical Education & Training Creation, development, production and dissemination (internally and externally) of non-promotional disease and treatment-related materials that educate specifically with medicine or healthcare.
  • Medical Infographics Creation of visually engaging, concise graphic summaries to rapidly convey complex clinical data, scientific concepts, or statistical results.
  • Medical Information: Sites and Programs Developing online educational platforms or live programs that provide HCPs and patients with comprehensive, compliant, and current medical information.
  • Medical Literature Reviews Systematic searching, appraisal, and synthesis of published scientific literature to generate evidence-based reports on a specific topic, disease, or treatment.
  • Medical Publications Make clear and accurate presentations of scientific and technical data.
  • Medical Q&As Developing pre-approved, standardized documents containing accurate, balanced answers to anticipated scientific inquiries about a product or disease.
  • Medical Science Liasion (MSL) Training Training for medical science liaisons who want to work in pharmaceutical, biotechnology, medical device, and managed care companies.
  • Medical Writing and Editing/Manuscript Development Communicate scientific, technical and health-related information to a range of audiences.
  • Meeting and Events A gathering of people with a shared purpose, often for business or organizational goals
  • Moderation (by Therapeutic Experts or BHBIA-Certified Moderators) Professional facilitation of qualitative sessions by trained moderators with therapeutic expertise or compliance certification. Ensures data quality and regulatory adherence during interviews or focus groups.
  • Other Medical Affairs Videos Develop and design Medical Affair videos that are explainer videos and or augmented/virtual reality experiences.
  • Patient Advocacy Group Engagement Compliant collaboration and information sharing with non-profit organizations that represent patient communities to understand their needs and provide education.
  • Patient Narratives Compliant collection and use of individual patient stories to illustrate the impact of a disease or treatment, often for training or empathy-building purposes.
  • Poster Design and Development Design and Develop Posters for Poster Symposiums and conferences to effectively convey science information.
  • Poster Symposia, Summits, Product Theaters, etc. Support Comprehensive planning and execution support for organized, large-scale medical meetings and events used to present and discuss clinical data and research.
  • Press Materials Associated with Key Publications Development of compliant communications such as press releases or media alerts for journalists and stakeholders, summarizing the data published in a major scientific journal.
  • Proactive and Reactive Medical Affairs Assets Development of both planned educational materials and responsive documents used by Medical Affairs to address scientific information gaps.
  • Publication Writing Create further publication documents. Investigational device exemptions (IDEs) BLAs, MAA, PMA, eCTDs, informed consents, CMC and manufacturing reports, orphan drug designations (ODD), briefing books.
  • Publications Plan Development & Management Strategic planning and oversight of all research dissemination activities, including outlining target journals, timelines, authors, and compliance for clinical data publications.
  • Review Article/ Submission Drafting and managing the process of submitting an objective, comprehensive summary of the current literature on a disease or treatment area to a peer-reviewed journal.
  • Roundtable Meeting A roundtable meeting is a collaborative, peer-to-peer discussion where all participants are on an equal footing
  • Scientific Positioning Strategic development of the evidence-based argument that defines how a drug or therapy is distinct, superior, or beneficial relative to competitors in the market.
  • Scientific Share of Voice Measurement Quantitative analysis tracking the volume and nature of a company's, or a competitor's, scientific discussion across publications and medical meetings.
  • Scientific Training Solutions Developing comprehensive educational programs and materials to ensure internal teams, field medical staff, or external partners are fluent in the therapeutic area and product data.
  • Strategic Medical Communication Development & Planning High-level planning to define the core scientific messages and the tactical strategy needed to effectively convey clinical data to key stakeholders over time.
  • Survey to KEE’s, External Expert Mapping Conducting compliant research and analysis to identify, categorize, and gather feedback from influential external medical and scientific experts.

Primary Market Research

  • Adherence, Satisfaction, and Switch Behavior Studies Explores factors driving treatment compliance, satisfaction, and switching behavior. Guides patient support initiatives and product differentiation.
  • Conjoint analysis / Discrete Choice Modeling (DCM) Respondents evaluate hypothetical product profiles with varying features to identify trade-offs. Delivers utility scores for product attributes and preference shares to guide product and pricing strategy.
  • Journey Mapping (Patient, HCP, Payer) Visual representation of stakeholder experiences across disease or treatment timelines. Identifies pain points, decision triggers, and opportunities for engagement or support.
  • Online/phone surveys Quantitative questionnaires deployed via web or telephone to gather feedback from large, targeted populations. Results offer statistically significant insights for trend analysis, segmentation, and tracking.
  • Survey Programming and Testing (e.g., Confirmit, Decipher) Technical implementation of survey instruments with logical flow and error checking across platforms. Delivers validated and tested surveys ready for field deployment.

Public Affairs

  • Internal Communications Newsletters describing the process and updates related to the clinical trial.

Real World Evidence & Data

  • Claims Data & Database Analysis Analysis of care cost and quality.
  • Cohort Study Investigating the causes of disease to establish links between risk factors and health outcomes.
  • Meta-Analysis Use quantitative statistical approaches to pool results across multiple studies to improve power or resolve uncertainty; may be used in conjunction with a systematic review.
  • Real World Evidence (RWE) Studies Studies (prospective or retrospective) utilizing data obtained from "real world settings" , and is outside the tight controls of a clinical trial design.
  • Real-World Data Acquire real-world data from patients' electronic medical records including clinical information generated during the course of healthcare.
  • Real-World Evidence Acquire clinical data from patients' medical records to analyze trends and the frequency of occurrence of different medical conditions.
Show all 12 in Real World Evidence & Data 6 more
  • Registries - Disease Database containing, through utilizing observational research methods, standardized data about patients who have the same disease.
  • Retrospective Exploratory Studies Retrospective exploratory studies
  • RWE/HEOR Data Analysis Analysis that helps you make sense of your RWE/HEOR data
  • RWE/HEOR/Market Access Safety Surveillance Monitor safety of treatment and determine methods to identify adverse events early
  • RWE/RWD Observational Research Research method for documenting clinical, economic, and or humanistic outcomes of actual medical practice absent the constraints of a more formal experimental design. See also Pragmatic Clinical Trials.
  • Secondary Real World Evidence Analyze clinical trial data.

Regulatory Affairs

  • Post Authorization Efficacy Study (PAES) Answer uncertainties in efficacy of treatment, and improve understanding of treatment and the benefit-risk profile. These studies are specifically asked for by European Medicines Agency (EMA) to continually grant...
  • Post Authorization Safety Study (PASS) Evaluate the safety, benefit-risk profile, and risk management of a treatment. These studies are specifically asked for by European Medicines Agency (EMA) and they can be mandatory or voluntary.
  • Post Launch EMA Consulting Post-launch European Medicines Agency (EMA) consulting assists pharmaceutical and biotech companies with the ongoing, post-authorisation phase of drug lifecycles.
  • Post Launch FDA Consulting Post-Launch FDA consulting refers to specialized regulatory services that help companies maintain compliance and monitor product safety after a drug or medical device is approved for the U.S. market
  • Preparation Of Regulatory Dossiers Preparation of regulatory dossiers is the process of compiling detailed administrative, clinical, and scientific data into a standardized format
  • Risk Benefit Assessment Determine ratio of treatment risk to the potential benefits.
Show all 7 in Regulatory Affairs 1 more
  • Strategic Regulatory Advice Strategic Regulatory Advice involves expert guidance that helps businesses navigate complex legal and industry standards to achieve market access and maintain compliance. It serves as a blueprint for aligning business...

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • Spain Barcelona 1 site

Source: Scientist.com supplier network (site locations)

Get the Adelphi Targis, S.L report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network.

Work with Adelphi Targis, S.L on Scientist.com

For prices, more details, or to contact Adelphi Targis, S.L, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.